Drawing for MEDIPILL

USPTO serial 77869329

MEDIPILL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PARK, JENNY K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDIPILL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin St-Amant

MARTIN ST-AMANT CAIN LAMARRE CASGRAIN WELLS580 GRANDE-ALLEE ESTSUITE 440QUEBEC, G1R2K2

Goods and services

ClassDescriptionStatusFirst use
009software for capturing, organizing, storing, transmitting and safekeeping patient's medical records including the dosage of medication for a particular patient as well as the patient's allergies to medication and creatinine clearanceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 14, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 14, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 31, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 30, 2011EX1GSOU EXTENSION 1 GRANTED—
Mar 29, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 21, 2011EXT1SOU EXTENSION 1 FILED—
Mar 21, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 27, 2010ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Apr 27, 2010ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 13, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 13, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 9, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2010ALIEASSIGNED TO LIE—
Feb 17, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 17, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Feb 17, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 17, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 17, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 16, 2010DOCKASSIGNED TO EXAMINER—
Nov 17, 2009MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Nov 16, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance